SCHEMBL4674841

SCHEMBL4674841

Cc1ccc2[nH]cc(C3CC[N]CC3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.50
GABRP O00591 1/20 0.49
GABRD O14764 1/20 0.49
GABRA1 P14867 1/20 0.49
GABRB1 P18505 1/20 0.49
GABRG2 P18507 1/20 0.49
GABRB3 P28472 1/20 0.49
GABRA5 P31644 1/20 0.49
GABRA3 P34903 1/20 0.49
GABRA2 P47869 1/20 0.49
GABRB2 P47870 1/20 0.49
GABRA4 P48169 1/20 0.49
GABRE P78334 1/20 0.49
GABRA6 Q16445 1/20 0.49
GABRG1 Q8N1C3 1/20 0.49
GABRG3 Q99928 1/20 0.49
GABRQ Q9UN88 1/20 0.49
HTR1B P28222 4/20 0.48
HTR1D P28221 4/20 0.48
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4676876 0.88 IDO1 (0.50) IDO1GABRPGABRDGABRA1GABRB1
SCHEMBL18474334 0.84 IDO1 (0.52) IDO1GABRPGABRDGABRA1GABRB1
SCHEMBL3832948 0.83 HTR2C (0.62) IDO1GABRPGABRDGABRA1GABRB1
Hydrochloric Acid SCHEMBL30375480 0.82 HTR2C (0.63) IDO1GABRPGABRDGABRA1GABRB1
SCHEMBL4674713 0.82 SLC6A4 (0.58) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL4674995 0.82 CYP2C9 (0.66) HTR1BHTR1DCYP1A2CYP3A4CYP2D6
SCHEMBL4676670 0.82 SLC6A4 (0.58) IDO1HTR1BSLC6A4HTR1AHTR2A
SCHEMBL4671021 0.81 HTR2A (0.59) IDO1CYP1A2SLC6A4HTR1AHTR2A
SCHEMBL23010847 0.81 HTR1D (0.72) HTR1BHTR1DCYP1A2CYP3A4CYP2D6
SCHEMBL4674563 0.78 SLC6A4 (0.64) IDO1HTR1BSLC6A4HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed